Notably, BRN2-mediated repression of MITF transcription represents a mechanism distinguishing between melanoma cells and melanocytes due to the lack of BRN2 expression in the latter, which might be explained by the involvement of melanoma-specific BRAFV600E in BRN2 upregulation [73]. The gene discussed is MITF; the disease is melanoma.